Grown Rogue International (GRUSF) Share-based Compensation (IS) (2012 - 2019)
Grown Rogue International (GRUSF) posted quarterly Share-based Compensation (IS) of $112080.0 for Q2 2019, up 115.27% quarter-over-quarter from $52065.5 in Q3 2018.
Grown Rogue International (GRUSF) Share-based Compensation (IS) (2012 - 2019) Analysis & Trends
Grown Rogue International's Share-based Compensation (IS) history runs 7 years deep, the most recent figure standing at $112080.0 for Q2 2019.
- In Q2 2019, Share-based Compensation (IS) changed N/A year-over-year to $112080.0; the TTM figure through Apr 2019 stood at $231277.2 (changed N/A YoY), while the FY2018 annual figure was $156197.3, down 87.23% from the prior year.
- Share-based Compensation (IS) for Q2 2019 stood at $112080.0, up from $52065.5 in the prior quarter.
- The five-year high for Share-based Compensation (IS) was $1.1 million in Q3 2017, with the low at -$105052.6 in Q3 2016.
- The 5-year median for Share-based Compensation (IS) is $52065.5 (2018), against an average of $208177.2.
- The sharpest annual moves came in 2016 and 2017: Share-based Compensation (IS) slumped 550.63% in 2016, then jumped 1192.59% in 2017.
- Grown Rogue International's Share-based Compensation (IS) stood at $23312.4 in 2015, then jumped by 341.4% to $102900.8 in 2016, then surged by 1015.44% to $1.1 million in 2017, then sank by 95.46% to $52065.5 in 2018, then jumped by 115.27% to $112080.0 in 2019.
- Business Quant data shows GRUSF's Share-based Compensation (IS) at $112080.0 in Q2 2019, $52065.5 in Q3 2018, and $26546.3 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2019 | 112,080.00 |
| Apr 30, 2019 | 112,080.00 |
| Aug 31, 2018 | 52,065.51 |
| Aug 31, 2018 | 52,065.51 |
| May 31, 2018 | 26,546.28 |
| May 31, 2018 | 26,546.28 |
| Feb 28, 2018 | 40,585.43 |
| Feb 28, 2018 | 40,585.43 |
| Aug 31, 2017 | 1.15 Mn |
| Aug 31, 2017 | 1.15 Mn |
| Nov 30, 2016 | 102,900.79 |
| Nov 30, 2016 | 102,900.79 |
| Aug 31, 2016 | -105,052.59 |
| Aug 31, 2016 | -105,052.59 |
| May 31, 2016 | 473,363.01 |
| May 31, 2016 | 473,363.01 |
| Aug 31, 2015 | 23,312.40 |
| Aug 31, 2015 | 23,312.40 |
| Nov 30, 2014 | 75,653.09 |
| Nov 30, 2014 | 75,653.09 |